Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Spotlight Innovation
AddedFeb 15, 2024
UpdatedJun 28, 2026
Spotlight Innovation

Spotlight Innovation

Public

Iowa-based pharmaceutical firm aiding in the commercialization of US healthcare tech innovations.

HQ
West Des Moines, IA, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Spotlight Innovation, founded in West Des Moines, Iowa, is a pharmaceutical company dedicated to aiding the commercialization of healthcare technologies developed in leading American academic laboratories. The company's core mission is to bridge the gap between groundbreaking research and market-ready products, thereby enhancing healthcare outcomes. Spotlight Innovation focuses on identifying, acquiring, and advancing innovative healthcare solutions, particularly in the pharmaceutical sector.

Notable affiliated individuals include experts from both the pharmaceutical industry and academic institutions, although specific names are not provided. The company has successfully facilitated the transition of several healthcare technologies from research to market, demonstrating a significant impact on the accessibility and effectiveness of new medical treatments. Through strategic partnerships and investments, Spotlight Innovation continues to play a crucial role in bringing cutting-edge healthcare innovations to the public.

Spotlight Innovation - Quick Facts

When was Spotlight Innovation founded?

Spotlight Innovation was founded in 2006.

Where is Spotlight Innovation's headquarters located?

Spotlight Innovation's headquarters is located in West Des Moines, IA, US.

When was Spotlight Innovation's last funding round?

Spotlight Innovation's most recent funding round was for $2.5M (USD) in April 2015.

How much has Spotlight Innovation raised to-date?

As of Apr 28, 2015, Spotlight Innovation has raised a total of $2.5M (USD).

How many employees does Spotlight Innovation have?

Spotlight Innovation has 2 employees as of Feb 5, 2024.

Spotlight Innovation - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • SaaS
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 23 more industry codes
NAICS
  • 210000Mining, Quarrying, and Oil and Gas Extraction
  • 213000Support Activities for Mining
  • 213100Support Activities for Mining
  • 213110Support Activities for Mining
  • 213112Support Activities for Oil and Gas Operations
  • 230000Construction
  • 237000Heavy and Civil Engineering Construction
  • 237100Utility System Construction
  • 237120Oil and Gas Pipeline and Related Structures Construction
  • 238000Specialty Trade Contractors
  • 238900Other Specialty Trade Contractors
  • 238910Site Preparation Contractors
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 1300Oil And Gas Extraction
  • 1380Oil And Gas Field Services
  • 1389Oil And Gas Field Services, Not Elsewhere Classified
  • 2000Food And Kindred Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 910Support activities for petroleum and natural gas extraction